Navigation Links
Book by UCR biologist tells story of 100-year quest for elusive malaria vaccine
Date:9/29/2009

RIVERSIDE, Calif. A deadly disease, malaria afflicts 350-500 million people worldwide each year and kills more than a million people. Transmitted by Anopheles mosquitoes, the disease occurs in more than 100 countries and territories, with at least 40 percent of the world's population at risk.

Understandably, an area of intensive research is the development of an effective malaria vaccine. Yet, despite decades of research that has resulted in four Nobel prizes awarded for malaria work, no effective vaccine against the disease has been introduced into clinical practice. Indeed, the year 2010 will mark the hundredth anniversary of the first attempt at a malaria vaccine.

Now in his book, The Elusive Malaria Vaccine: Miracle or Mirage? (American Society for Microbiology Press, 2009), Irwin Sherman, a professor emeritus of biology at the University of California, Riverside, chronicles the 100-year quest for the still-elusive vaccine.

"I wrote this book to make the science of malaria vaccines accessible and understandable to a general audience," Sherman said. "In the book I offer insight into the problems associated with the development of malaria vaccines and I address the public's curiosity about them, as well as the reasoning behind the need for developing vaccines."

A legitimate question that may be asked is why a protective vaccine against malaria has remained so elusive. The problem, according to Sherman, does not lie in a lack of communication.

"After all, stories of malaria vaccines have been told in thousands of scientific papers, in newspaper and magazine articles," he said. "I believe the fault lies in the fact that the message for a protective vaccine has not been specifically addressed to a general audience so that an under
'/>"/>

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. New book by UCR biologist discusses 12 diseases that impacted humanity
2. Stanford biologist awarded 2008 Sophie Prize in Norway
3. Biologists Discover How Dengue Virus Matures
4. Boston College biologists build a better mouse model for cancer research
5. UCR cell biologist co-leads joint international conference on wound healing
6. Microbiologists receive top Canadian recognition
7. Reeve Foundation Recruits Distinguished Stem-Cell Neurobiologist - The Salk Institutes Samuel L. Pfaff, Ph.D. - to its International Research Consortium
8. Cell biologists identify new tumor suppressor for lung cancer
9. Biologist finds plant polymerases IV and V are really variants of Polymerase II
10. Where tumor cells boldly go: Weill Cornell cancer biologists shed light on the metastatic niche
11. Biologists Question Animal Brain Size Theory

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Book by UCR biologist tells story of 100-year quest for elusive malaria vaccine
Book by UCR biologist tells story of 100-year quest for elusive malaria vaccine
(Date:11/23/2009)...lation of arsenic compounds appears to cause oxida...ity, according to a new study published online Nov...stitute . , Although biomethylation was once bel...ught to enhance its toxicity and potentially its c...c biomethylation in oxidative DNA damage in mice, ...
(Date:11/23/2009)...s saw their odds drop by 63 percent with moderate-...ov. 23 (HealthDay News) -- Moderate-to-high intens...ay help reduce stroke risk in older men but not in...d almost 3,300 men and women, average age 69, in M...uring that time, there were 238 strokes among the ...
(Date:11/23/2009)...artnershipswithMinorityBanksin Washington D.C.... S.C. IntendedtoSpurEconomicGrowthandRevitalizati...ire/--DaVita,thenation,sleadingproviderofdialysiss...heAnacostiacommunityfora$1millioninvestmentinIndus...oritycommunities. ,, DaVita,sinvestmentinWashin...
(Date:11/23/2009)...LLAS,Nov.23/PRNewswire/-- ,, WHAT: ,, The...erylCompanies, thenation,sleadinghealthcareexclus...tivelyreachconsumersineverygenerationwithapositive...erCEOofMinuteClinic,thisWebinarwillsupplementHowe,...nalPerspective,"whichdiscusseshowconsumerswillulti...
(Date:11/23/2009)...WYORK,Nov.23/PRNewswire/--Howistheeconomyaffecting...mp;SaatchiWellnessonWellness&theEconomy,theeco...ftsfromahealthylifestyleofexerciseanddiettoonethat...mate. ,, Thesurvey,smostdramaticfindingwasthech...romatraditionalfocusonhealthandwellbeingtotoday,sm...
Breaking Medicine News(10 mins):Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 4Health News:Tips to Improve Healthcare Customer Service Across All Generations 2Health News:Being Well Is About Reinvention - Not Health 2Health News:Being Well Is About Reinvention - Not Health 3
...vation Management Group,Inc. (IMG) announced today...low cost, full screen magnification software. Most... designed for individuals who have extreme visual,...riced within the reach of the average computer use...
...it National,Patient Advocate Foundation (NPAF), re...ted nationally in more than a decade through our,d...Foundation (PAF),continues to routinely receive in...g and chronic conditions, continue to,seek informa...
...sed wisely and in the right patients, experts say ...h Friday,s announcement of almost $5 billion to be...by the now-withdrawn painkiller Vioxx, the drug,s ...he focus back on the medications once again. , Cox...
...nome Sciences,Inc. (Nasdaq: HGSI ) announced toda...or Focus Conference will be webcast and may be acc....newscom.com/cgi-bin/prnh/20010612/HGSLOGO ) A m... Investors interested in listening to the live web...
...Nasdaq: MASI ),the inventor of Pulse CO-Oximetry ...imetry, announced today that the Pricing Committee...stockholder rights plan. "This plan is designed t...ce to all stockholders or are otherwise,not in the...
...ng-Plough,Corporation (NYSE: SGP ) will provide a... Bertolini, executive vice president and chief fin...are Conference in Phoenix,Ariz., on Nov. 13, 2007,...-Plough corporate Web site, http://www.schering-pl...
Other Medicine News:Health News:IMG Announces an Affordable Full Screen Software Magnifier for Home and Business Users 2Health News:National Patient Advocate Foundation (NPAF) Statement Regarding New FDA Label on Erythropoietin Stimulating Agents (ESAs) 2Health News:Vioxx Settlement Puts Painkillers Back in the Spotlight 2Health News:Vioxx Settlement Puts Painkillers Back in the Spotlight 3Health News:Vioxx Settlement Puts Painkillers Back in the Spotlight 4Health News:Masimo Corporation Adopts Stockholder Rights Plan 2Health News:Masimo Corporation Adopts Stockholder Rights Plan 3
(Date:11/23/2009)...wswire-FirstCall/-- CryoLife,Inc. (NYSE: CRY ),ani...tissueprocessingcompany,announcedtodaythatitissche...ualHealthCareConferenceatTheNewYorkPalaceHotelonDe...hiefexecutiveofficerofCryoLife,Inc.,willprovideaco...ntsandhostaquestionandanswersessionat4:30p.m.Easte...
(Date:11/23/2009)....23/PRNewswire-FirstCall/--WoundManagementTechnolo...oviderofspecialtymedicalproducts,announcedthatitha...ehensivemanagementbusinessupdatetoillustratethedev...alesincreased33.5%to$102,926vs.Q32008salesof$77,08...o$3,327,892vs.Q32008shareholderequityof$(321,257) ...
(Date:11/23/2009)...23/PRNewswire-FirstCall/--Pharmasset,Inc.(Nasdaq: ...byitspartnerRoche(SWX:ROG.VX;RO.S,OTCQX:RHHBY),wil...theongoingphase2btrialofRG7128,afirst-in-classnucl...ronichepatitisCvirus(HCV)infection.Thedecisionwasr...toringCommittee(DMC)ofallavailablesafetydatafromth...
Breaking Medicine Technology:CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Children Uniting Nations Russell Simmons Mos Def David Archuleta Terrence Howard Gabrielle Union Vivica Fox Elise Neal and Shawn King Visit 48163 1Children Uniting Nations Russell Simmons Mos Def David Archuleta Terrence Howard Gabrielle Union Vivica Fox Elise Neal and Shawn King Visit 48163 2RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 1RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 2RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 3RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 4RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 5RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 6CVS Caremark Ranks Among 50 Best Fertility and Adoption Friendly Workplaces in America 48156 1CVS Caremark Ranks Among 50 Best Fertility and Adoption Friendly Workplaces in America 48156 2CVS Caremark Ranks Among 50 Best Fertility and Adoption Friendly Workplaces in America 48156 3
... an emerging,research-based pharmaceutical company...ation (FDA) has granted Orphan Drug Designation to...tment of chronic lymphocytic,leukemia (CLL). A Pha...ic,in Rochester, Minnesota where researchers are s...henon E in CLL patients., "The FDA Orphan Drug De...
...a,Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced...inical trial with AZ-004 (Staccato(R) loxapine).,A...eloped for the treatment,of acute agitation in pat...za believes the novel, non-invasive nature and rap...inhaled loxapine administration via the,Staccato s...
Other Medicine Technology:Polyphenon Pharma Receives Orphan Drug Designation for Its Botanical Drug, Polyphenon E, for the Treatment of CLL 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6
No.12 Surgical Blade
Standard
Rib Back
BD Beaver Phaco slit blade
Medicine Products: